AF
LENZ

Allworth Financial’s LENZ Therapeutics LENZ Stock Holding History

Allworth Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19K Buy
385
+129
+50% +$1.04K ﹤0.01% 4478
2026
Q1 		$2.34K Buy
256
+236
+1,180% +$3.31K ﹤0.01% 4301
2025
Q4 		$320 Hold
20
– – ﹤0.01% 4625
2025
Q3 		$932 Hold
20
– – ﹤0.01% 4276
2025
Q2 		$587 Sell
20
-15
-43% -$408 ﹤0.01% 4094
2025
Q1 		$1K Buy
+35
New +$862 ﹤0.01% 3469

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Allworth Financial's LENZ Position: Q2 2026 in Review

Allworth Financial increased its LENZ Therapeutics (LENZ) stake by 50% in Q2 2026, buying an estimated $1.04K and bringing the position to 385 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #4478.

Allworth Financial first reported a position in LENZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.34K in Q1 2026. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Allworth Financial held 385 shares of LENZ Therapeutics worth $2.19K as of Q2 2026.
  • Allworth Financial bought 129 LENZ Therapeutics shares in Q2 2026, an estimated $1.04K.
  • LENZ Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4478 holding.
  • Allworth Financial first reported a position in LENZ Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Allworth Financial's LENZ Therapeutics position peaked at $2.34K in Q1 2026.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.